期刊文献+

腹腔镜直肠癌根治术对血清血管内皮生长因子C和可溶性白介素-2受体水平的影响及临床意义 被引量:1

Study on VEGF-C and sIL-2R in blood associated with laparoscopic radical resection of rectal cancer
下载PDF
导出
摘要 目的探讨腹腔镜结直肠癌根治术对血清血管内皮生长因子C(VEGF-C)和可溶性白介素-2受体(sIL-2R)表达影响及其临床意义。方法收集2004年11月~2006年11月该院行根治性直肠癌手术患者150例,其中,腹腔镜组50例,开腹组100例,采用双抗体夹心酶联免疫方法(ELISA)检测两组术前和术后不同时期血清VEGF-C和sIL-2R水平,并进行两组间比较。结果腹腔镜组患者血清VEGF-C水平从术后第3天开始一直呈下降趋势,于术后第10天时已明显低于术前水平(P<0.05);而开腹组患者术后第3天血清VEGF-C水平出现升高,之后逐渐下降,术后1个月时明显低于术前水平(P<0.05),术后第3、7天与腹腔镜组同期比较差异有显著性(P<0.05)。两组患者术前血清sIL-2R从术后第3天开始两组患者血清sIL-2R水平水平均呈下降趋势,于术后第10天时均明显低于术前水平(P<0.05)。结论腹腔镜手术治疗直肠癌比传统开腹手术可能更具有优势,规范操作下不会增加肿瘤侵袭转移机会,安全性较好。 【Objective】To study the clinical significance of changes of serum SIL-2R and TNF-αlevels after laparoscopic radical resection of rectal cancer.【Methods】150 patients with rectal cancer were divided into laparoscopic operation group (50 cases)and open operation group (100 cases) randomly.Enzyme linked immunosorbent assay (ELISA) was used to detect the level of vascular endothelial growth factor C and solute IL-2R in serum before and afer operation.【Results】The serum VEGF-C level in the laparoscopic operation group decreased gradually after operation for 3 days and reached the lowest value on postoperative for 10 days (P 0.05).The serum VEGF-C level was significantly high in the laparoscopic operation group than that in the laparoscopic operation group on postoperative for 3,7 days respectively (P 0.05).The serum sIL-2R level in the laparoscopic operation group decreased gradually after operation for 3 days and reached the lowest value on postoperative for 10 days(P 0.05).【Conclusions】The laparoscopic radical resection of rectal cancer could not raise the possibility of tumor metastasis compared with the open operation.
出处 《中国内镜杂志》 CSCD 北大核心 2010年第11期1137-1139,共3页 China Journal of Endoscopy
关键词 腹腔镜 直肠癌 血管内皮生长因子C 可溶性白介素-2受体 laparoscopy rectal cancer vascular endothelial growth factor C solute IL-2R
  • 相关文献

参考文献9

  • 1陈宏宇,韩毅,慕刚,柳青,梁栋,宋文君.血管内皮生长因子C的研究进展[J].中国组织工程研究与临床康复,2008,12(11):2138-2142. 被引量:10
  • 2T SKOBE M, HAWGHORAT T, JACKSON DG, et al. Induction of tumor lymphagiogeesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med, 2001, 7(2): 192-198.
  • 3孙志勇.直肠癌患者手术前后血清SIL-2R、TNF-α检测的临床意义[J].放射免疫学杂志,2005,18(6):441-442. 被引量:3
  • 4WITKOWSKA AM. On the role of sIL-2R measurements in rheumatoid arthritis and cancers [J]. Mediators Inflamm, 2005, 2005(3): 121-130.
  • 5MARCO B, ANDREA V, LUCA G, et al. Laparoscopic versus open colorectal surgery: A randomized trial on short-term out- come[J]. Ann Surg, 2002, 235: 759-757.
  • 6VAN TRAPPEN, STEELE D, LOWE DG, et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D and their receptor VEGFR-3, during different stages of cervical car- cinogenesis[J]. J Pat, 2003, 201(4): 544-555.
  • 7NATHANSON SD. Insights into the mechanisms of lymph node metastasis[J]. Cancer, 2003, 98(2): 413-423.
  • 8SKOBE M, HAMBERG LM, HAWIGHORST T, et al. Concurrent induction of lymph angiogenesis,and macrophage recruitment by vascular endothelial growth factor C in melanoma [J]. Am J Path, 2001, 159(3): 893-903.
  • 9MURAKAMI S. Soluble interleukin-2 receptor in cancer[J]. Front Biosci, 2004, 9(10): 3085-3090.

二级参考文献40

  • 1何龙.细胞因子自分泌现象及其生理和病理意义(文献综述)[J].上海免疫学杂志,1994,14(3):184-187. 被引量:34
  • 2Rubin LA,Nelson DL.The soluble interleukin-2 receptor:Biology function and clinical application.Ann Inter Med.1990,113:619.
  • 3Rubin LA,Nelson DL.Soluble interleukin-2 receptors are released by activated human lymphoid cell in vitral.J Immunol.1985,135:3172.
  • 4Robble RL.Conversion of low-affinity interleukin-2 receptor to high affinity state floolwing fusion of cell membrane.Proc Natle Cand Sci USA.1986,83:2992.
  • 5Kaipainen A,Korhoren J,Taipale J,et al. Expression of the fmslike tyrosine kinase FLT-4 gene becomes restricted to endothelium of lyphatic vessels during development. Proc Natl Acad Sci USA 1995:92(8):3566-3570
  • 6Paavonen K,Horelli-Kuitunen N,Chilov D et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34,respectively. Circulation 1996;93:1079-1082
  • 7Joukov V, Pajusola K,Kaipainen A, et al. A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4(VEGFR-3) and KDR(VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15(7): 1751
  • 8Kukk E,Lymboussaki A,Taira S,et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996; 122:3829-3837
  • 9Karkkainen MJ, Haiko P, Saimo K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5(1) :74-80
  • 10Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997;16:3898-3911

共引文献11

同被引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部